This review discusses potential multifactorial mechanisms by which COX-2 selective inhibitors may increase cardiovascular risk.
Answers are grounded in this paper and cite their sources.
May warrant caution with COX-2 inhibitors in high-risk patients; leaves open precise mechanistic confirmation and risk thresholds.
It appears that in COX-2 selective inhibitors may increase the risk of major adverse cardiovascular events. Various potential mechanisms are presented whereby COX-2 selective inhibitors may enhance the risk of cardiovascular events in certain patients. It is conceivable that different mechanisms may be involved in different circumstances and that multifactorial mechanisms may occasionally be operating in conjunction with one another.
No takes yet. Share an insight, caveat, or question.
Howard S. Smith (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: